Health Cytokinetics Unveils Promising Heart Drug Data at ESC25 Conference Cytokinetics has announced significant findings regarding its cardiac myosin inhibitor, aficamten, which may redefine treatment protocols for a specific heart muscle disorder. The data... Editorial14 hours ago